Vista Pharmaceuticals informs about updates

27 Jun 2025 Evaluate
Vista Pharmaceuticals has informed that the objects of the preferential issue as mentioned in the Explanatory Statement to the notice dated 19.02.2025 convening the EGM on 20.03.2025 are as follows: the Company intends to utilize the net proceeds from this Preferential Issue towards the following objects: Working capital requirement; Repayment of Loans availed from Banks/ Financial Institution; Expansion of business activities; General corporate purposes; Investment in future projects: EGM on 20.03.2025 approved the preferential issue to raise a sum of 58.65 crores, Since the preferential issue is for a sum less than hundred crores, monitoring agency was not appointed and the amount of funds proposed to be utilised against each object was not stated. The detailed break up for each object was not mentioned in the Explanatory Statement since preferential issue size is only 58.65 crores. 

The above information is a part of company’s filings submitted to BSE.

Vista Pharma Share Price

8.69 0.00 (0.00%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×